Brief: Tianjin Development Says Lisheng Pharmaceutical Proposed Partnership Agreement To Form Fund
22/08/2025 03:01
Aug 22 (Reuters) - Tianjin Development Holdings Ltd 0882.HK: LISHENG PHARMACEUTICAL PROPOSES PARTNERSHIP AGREEMENT FOR FUND FORMATION FUND FORMATION WITH TOTAL CAPITAL COMMITMENT OF RMB500 MILLION LISHENG PHARMACEUTICAL TO COMMIT RMB173.75 MILLION TO FUND Further company coverage: 0882.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln